ASSELAH, J.; SPERLICH, C. Post-docetaxel options for further survival benefit in metastatic castration-resistant prostate cancer: Questions of choice. Canadian Urological Association Journal, [S. l.], v. 7, n. 1-2-S1, p. S11-S17, 2013. DOI: 10.5489/cuaj.274. Disponível em: https://cuaj.ca/index.php/journal/article/view/274. Acesso em: 12 may. 2024.